3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients
Leave reply:
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Follow Kairos Ventures on LinkedIn
Subscribe to Kairos News
Recent Posts
- TRIA™ Polymer Surgical Valves Surpass 200 Patient Life Years
- Linnaeus Therapeutics Announces Issuance of Composition of Matter Patent for LNS8801 by the European Patent Office
- Sienza Energy, a Caltech-Incubated Battery Company, announces its 3D pure silicon anode gravimetric capacity
- Liquidmetal Technologies and Amorphology, Inc. Enter into a Manufacturing License Agreement
- MemVerge and Micron Boost NVIDIA GPU Utilization with CXL® Memory